Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	300.75	296.78	242.69	294.27	212.68	124.97
Other Revenue	0.47	0.47	0.43	0.1	-	-
Revenue	301.21	297.24	243.12	294.37	212.68	124.97
Revenue Growth (YoY)	18.16%	22.26%	-17.41%	38.41%	70.19%	113.55%
Cost of Revenue	148.64	142.34	101.53	107.25	86	68.01
Gross Profit	152.57	154.9	141.59	187.12	126.69	56.96
Selling, General & Admin	99.07	105.94	74.47	60	50.96	29.69
Research & Development	37.74	33.37	41.91	32.19	19.03	20.51
Other Operating Expenses	2.88	2.21	-0.23	1.17	0.78	0.17
Operating Expenses	147.68	148.44	122.57	98.11	71.09	50.47
Operating Income	4.89	6.46	19.02	89	55.6	6.49
Interest Expense	-3.01	-3.12	-3.23	-4.98	-4.79	-2.45
Interest & Investment Income	37.39	31.14	36.3	17.98	9.07	3.56
Currency Exchange Gain (Loss)	2.4	2.4	0.87	2.24	-0.24	-0.53
Other Non Operating Income (Expenses)	-0.42	-0.05	-0.09	-0.14	-0.07	-0.15
EBT Excluding Unusual Items	41.25	36.84	52.89	104.09	59.57	6.91
Gain (Loss) on Sale of Investments	0.43	4.63	1.53	1.67	-	-
Gain (Loss) on Sale of Assets	0.09	0.09	-0.02	0.29	-0.02	-
Asset Writedown	-8.92	-7.51	-	-	-	-0
Other Unusual Items	2.86	2.38	7.26	13.38	8.61	4.77
Pretax Income	35.7	36.43	61.67	119.43	68.15	11.68
Income Tax Expense	20.32	16.19	8.41	14.06	7.76	-
Earnings From Continuing Operations	15.38	20.24	53.26	105.37	60.39	11.68
Minority Interest in Earnings	0.76	0.82	0.78	-	-	-
Net Income	16.14	21.05	54.04	105.37	60.39	11.68
Net Income to Common	16.14	21.05	54.04	105.37	60.39	11.68
Net Income Growth	-67.34%	-61.04%	-48.72%	74.47%	416.87%	-
Shares Outstanding (Basic)	110	111	115	101	86	86
Shares Outstanding (Diluted)	116	117	115	101	86	86
Shares Change (YoY)	1.22%	1.72%	13.48%	17.43%	0.20%	-
EPS (Basic)	0.15	0.19	0.47	1.04	0.70	0.14
EPS (Diluted)	0.14	0.18	0.47	1.04	0.70	0.14
EPS Growth	-67.74%	-61.70%	-54.81%	48.57%	415.84%	-
Free Cash Flow	3.37	-51.61	-19.59	-35.34	8.64	-33.04
Free Cash Flow Per Share	0.03	-0.44	-0.17	-0.35	0.10	-0.38
Dividend Per Share	0.420	0.420	0.440	0.429	-	-
Dividend Growth	-4.47%	-4.47%	2.66%	-	-	-
Gross Margin	50.65%	52.11%	58.24%	63.57%	59.56%	45.58%
Operating Margin	1.62%	2.17%	7.82%	30.23%	26.14%	5.19%
Profit Margin	5.36%	7.08%	22.23%	35.80%	28.40%	9.35%
Free Cash Flow Margin	1.12%	-17.36%	-8.06%	-12.01%	4.06%	-26.44%
EBITDA	42.59	42.22	47.04	113.28	74.34	21.98
EBITDA Margin	14.14%	14.21%	19.35%	38.48%	34.96%	17.58%
D&A For EBITDA	37.7	35.76	28.02	24.28	18.74	15.49
EBIT	4.89	6.46	19.02	89	55.6	6.49
EBIT Margin	1.62%	2.17%	7.82%	30.23%	26.14%	5.19%
Effective Tax Rate	56.92%	44.45%	13.63%	11.78%	11.39%	-
Revenue as Reported	301.21	297.24	243.12	294.37	212.68	124.97
Advertising Expenses	-	2.08	2.29	1.34	0.73	0.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.